Nampa

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease3 trials
• Atrial fibrillation1 trial
• Heart failure1 trial
• High blood pressure1 trial
• Ventricular tachycardia1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed2 trials
• Terminated2 trials

Lead sponsor

• AstraZeneca4 trials

Closed trials

• Completed

  Tracking Treatment Pathways in Adult Patients With Hyperkalemia.

  NCT05408039· AstraZeneca· Source

• Completed

  A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

  NCT05432167· Phase 2· AstraZeneca· Source

• Terminated

  A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

  NCT05056727· Phase 3· AstraZeneca· Source

• Terminated

  Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

  NCT04847232· Phase 3· AstraZeneca· Source